PATENT CLAIM ANALYSIS

Application Number: 16071546
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "171000"]

Abstract:
The present invention provides compositions and methods for inhibiting Dkk-1 for treating or preventing an inflammatory or inflammatory-related disease or disorder.

Claim (Index 11):
The method of  claim 9 , wherein the type 2 inflammation-related disease or disorder is selected from the group consisting of a parasite infection, cutaneous leishmaniasis, and asthma.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 95.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15664550', '15348345', '14160747', '13293911', '14689517']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.807012768504784
- 35 USC 102 Novelty (BERT): 0.5178069040703183
- Combined Prediction Score: 0.7780921820613375
- Mean Citation Score: 266.5903
- Max Citation Score: 277.23004
- Similarity Product: 159.12665576378583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test